Abeta polymerization through interaction with membrane gangliosides

Biochimica Et Biophysica Acta
Katsumi MatsuzakiKatsuhiko Yanagisawa

Abstract

Clarification of the molecular and cellular mechanisms underlying the assembly of amyloid beta-protein (Abeta) into insoluble fibrils in the brain has been one of the biggest challenges in the research on Alzheimer disease (AD). We previously identified a novel Abeta species, which was characterized by its tight binding to GM1 ganglioside (GM1), in the brain showing early pathological changes of AD. The ganglioside-bound Abeta (GAbeta) possessed unique characteristics, including its altered immunoreactivity, which suggests its distinct conformation from native Abeta, and its strong potency to accelerate Abeta assembly into fibrils. On the basis of these characteristics, it was hypothesized that Abeta adopts an altered conformation following interaction with GM1, leading to the generation of GAbeta, and then GAbeta acts as an endogenous seed for Alzheimer amyloid in the brain. To date, various in vitro and in vivo studies on GAbeta have revealed how Abeta binds to gangliosides, i.e., what are the favorable physicochemical and neurobiological conditions for generating GAbeta, and what is the pathological significance of ganglioside-induced Abeta assembly in the development of AD. Interestingly, GAbeta is favorably generated in th...Continue Reading

Citations

Mar 31, 2011·Nature Reviews. Neuroscience·Gilbert Di Paolo, Tae-Wan Kim
Dec 3, 2011·The Journal of Biological Chemistry·Robin B ChanGilbert Di Paolo
May 4, 2011·Cold Spring Harbor Perspectives in Biology·Francesc-Xabier ContrerasBritta Brügger
Nov 2, 2012·Skeletal Muscle·Alessandro FanzaniEugenio Monti
Jun 10, 2011·Experimental & Molecular Medicine·Dong Hoon KwakYoung Kug Choo
Jan 15, 2011·International Journal of Alzheimer's Disease·Jo V Rushworth, Nigel M Hooper
Feb 15, 2011·International Journal of Alzheimer's Disease·Maho Yagi-UtsumiKoichi Kato
Sep 23, 2011·Journal of Oleo Science·Robert K YuMakoto Yanagisawa
Jan 5, 2011·International Journal of Alzheimer's Disease·Aaron Y Lai, Joanne McLaurin
May 7, 2011·International Journal of Alzheimer's Disease·Masahiro KawaharaYutaka Sadakane
Feb 15, 2011·International Journal of Alzheimer's Disease·Katsumi Matsuzaki
Feb 26, 2011·International Journal of Alzheimer's Disease·Amany Mohamed, Elena Posse de Chaves
Feb 27, 2014·Bioanalysis·David Touboul, Mathieu Gaudin
Aug 26, 2014·Cellular and Molecular Life Sciences : CMLS·Tae-In KamYong-Keun Jung
Dec 17, 2010·Neurochemical Research·Makoto Yanagisawa
Dec 17, 2014·Life·Jillian E SmithDavid G Lynn
Oct 2, 2015·Biological & Pharmaceutical Bulletin·Maho Yagi-Utsumi, Christopher M Dobson
Jan 11, 2011·Journal of Neurochemistry·Katsuhiko Yanagisawa
Dec 3, 2014·Chemistry and Physics of Lipids·Tomasz Róg, Ilpo Vattulainen
Apr 2, 2014·Neurobiology of Aging·Sin Man LamGuanghou Shui
Jan 29, 2011·International Journal of Alzheimer's Disease·Toshio ArigaRobert K Yu
Jul 16, 2011·International Journal of Alzheimer's Disease·Olga Simakova, Nelson J Arispe
May 2, 2015·Glycoconjugate Journal·Maho Yagi-Utsumi, Koichi Kato
Apr 24, 2015·Glycoconjugate Journal·Katsuhiko Yanagisawa
May 9, 2012·Biochimica Et Biophysica Acta·Dhruva Dhavale, James E Henry
Oct 6, 2010·Biochimica Et Biophysica Acta·Aslin IzmitliJuan J de Pablo
May 27, 2014·Frontiers in Aging Neuroscience·Bruce X WongJames A Duce
May 6, 2016·International Journal of Molecular Sciences·Sun-Hyung HaCheorl-Ho Kim
Nov 8, 2014·Scientific Reports·Hirotsugu OgiYuji Goto
Jul 19, 2014·Langmuir : the ACS Journal of Surfaces and Colloids·Elena Del FaveroLaura Cantu'
Nov 28, 2017·Neuroscience Bulletin·Qiujian Yu, Chunjiu Zhong
Jan 1, 2013·Biomolecules·Annalisa ReliniAlessandra Gliozzi
Apr 6, 2018·Marine Drugs·Ashlin H TurnerChristina I Schroeder
Dec 14, 2017·Chembiochem : a European Journal of Chemical Biology·Naoya ItohKatsumi Matsuzaki
May 11, 2012·Dementia and Geriatric Cognitive Disorders·Z PernberM Blomqvist

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.